Počet záznamů: 1
Evaluation of 177Lu-nimotuzumab for Targeted Radioimmunotherapy of EGFR Expressing Tumors
- 1.BECKFORD, D. R., BALOGH, L., POSTENYI, Z., MATHE, D., EIGNER, S., EIGNER-HENKE, K., MONTANA, R. L., MELICHAR, F. Evaluation of 177Lu-nimotuzumab for Targeted Radioimmunotherapy of EGFR Expressing Tumors. European Journal of Nuclear Medicine and Molecular Imaging. 2012, 39(P0089), S327-S327. ISSN 1619-7070. E-ISSN 1619-7089.
Počet záznamů: 1